Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
human challenge model
Description:
A controlled clinical research model in which volunteers are exposed to an infectious agent to study disease or vaccine responses.
Related topics:
Salmonella and Campylobacter epidemiology (14%),
Influenza Virus Research Studies (12%),
Escherichia coli research studies (9%),
Mosquito-borne diseases and control (8%),
Malaria Research and Control (8%)
OpenAlex ID:
keywords/human-challenge-model
Human susceptibility and resistance to Norwalk virus infection
2003
·
Lisa Lindesmith
, Christine Moe
, et al.
·
Nature Medicine
·
1,269
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
2022
·
Ben Killingley
, Alex J. Mann
, et al.
·
Nature Medicine
·
572
PDF
Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model
2016
·
Matthew J. Memoli
, Pamela A. Shaw
, et al.
·
mBio
·
399
PDF
The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
2016
·
Beth D. Kirkpatrick
, Stephen S. Whitehead
, et al.
·
Science Translational Medicine
·
281
Vaccination against Shigellosis with Attenuated Shigella flexneri 2a Strain SC602
1999
·
Trinka S. Coster
, Charles W. Hoge
, et al.
·
Infection and Immunity
·
233
Inflammation induced by influenza virus impairs human innate immune control of pneumococcus
2018
·
Simon P. Jochems
, Fernando Marcon
, et al.
·
Nature Immunology
·
196
PDF
An Outpatient, Ambulant-Design, Controlled Human Infection Model Using Escalating Doses of Salmonella Typhi Challenge Delivered in Sodium Bicarbonate Solution
2014
·
Claire S. Waddington
, Thomas C. Darton
, et al.
·
Clinical Infectious Diseases
·
178
Predicting Susceptibility to Norovirus GII.4 by Use of a Challenge Model Involving Humans
2012
·
R. Frenck
, D. I. Bernstein
, et al.
·
The Journal of Infectious Diseases
·
158
A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics
2020
·
Marijke C. C. Langenberg
, Marie-Astrid Hoogerwerf
, et al.
·
Nature Medicine
·
155
PDF
A Human Challenge Model for Mycobacterium tuberculosis Using Mycobacterium bovis Bacille Calmette-Guérin
2012
·
Angela M. Minassian
, Iman Satti
, et al.
·
The Journal of Infectious Diseases
·
135
PDF
Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study
2020
·
David Liebowitz
, Keith Gottlieb
, et al.
·
The Lancet Infectious Diseases
·
126
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness
2011
·
V.J. Gunther
, R. Putnak
, et al.
·
Vaccine
·
118
The Oral, Live Attenuated Enterotoxigenic Escherichia coli Vaccine ACE527 Reduces the Incidence and Severity of Diarrhea in a Human Challenge Model of Diarrheal Disease
2012
·
Michael J. Darsley
, Subhra Chakraborty
, et al.
·
Clinical and Vaccine Immunology
·
107
Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage
2016
·
E. Mitsi
, A.M. Roche
, et al.
·
Mucosal Immunology
·
106
PDF
Refinement of a Human Challenge Model for Evaluation of Enterotoxigenic Escherichia coli Vaccines
2011
·
Clayton Harro
, Subhra Chakraborty
, et al.
·
Clinical and Vaccine Immunology
·
105
Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a
2016
·
Thomas C. Darton
, Claire Jones
, et al.
·
PLoS neglected tropical diseases
·
104
PDF
Randomized, Controlled Human Challenge Study of the Safety, Immunogenicity, and Protective Efficacy of a Single Dose of Peru-15, a Live Attenuated Oral Cholera Vaccine
2002
·
Mitchell B. Cohen
, Ralph A. Giannella
, et al.
·
Infection and Immunity
·
101
Prophylaxis of Plasmodium falciparum Infection in a Human Challenge Model with WR 238605, a New 8-Aminoquinoline Antimalarial
1998
·
Ralf P. Brueckner
, Trinka Coster
, et al.
·
Antimicrobial Agents and Chemotherapy
·
98
PDF
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study
2021
·
Jerald Sadoff
, Els De Paepe
, et al.
·
The Journal of Infectious Diseases
·
94
PDF
Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model
2017
·
Hazel C. Dobinson
, Malick M. Gibani
, et al.
·
Clinical Infectious Diseases
·
92
PDF
Two Studies Evaluating the Safety and Immunogenicity of a Live, Attenuated Shigella flexneri 2a Vaccine (SC602) and Excretion of Vaccine Organisms in North American Volunteers
2004
·
David E. Katz
, Trinka S. Coster
, et al.
·
Infection and Immunity
·
89
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
2021
·
Kawsar R. Talaat
, Cristina Alaimo
, et al.
·
EBioMedicine
·
86
PDF
Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model
2017
·
Jacqueline M. McBride
, Jeremy J. Lim
, et al.
·
Antimicrobial Agents and Chemotherapy
·
84
Successful Sporozoite Challenge Model in Human Volunteers with Plasmodium vivax Strain Derived from Human Donors
2009
·
Sócrates Herrera
, Olga Fernández
, et al.
·
American Journal of Tropical Medicine and Hygiene
·
80
PDF
Immune correlates of protection against influenza in the human challenge model.
2003
·
J Treanor
, P F Wright
·
PubMed
·
79
Show more works
View as search
Works count:
207
Citation count:
7,929
Year
Topic
Type